Premium
Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro‐oesophageal reflux‐induced chronic cough
Author(s) -
Dong Ran,
Xu Xianghuai,
Yu Li,
Ding Hongmei,
Pan Jing,
Yu Yiming,
Shi Cuiqin,
Chen Qiang,
Zhang Mengru,
Lv Hanjing,
Qiu Zhongmin
Publication year - 2019
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15169
Subject(s) - medicine , gabapentin , refractory (planetary science) , baclofen , reflux , chronic cough , anesthesia , omeprazole , gastroenterology , gastro , asthma , disease , agonist , physics , alternative medicine , receptor , pathology , astrobiology
Neuromodulators are considered potential therapeutic options for refractory gastro-oesophageal reflux-induced chronic cough.